Press releases

Year

January 8, 2026

AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference

December 30, 2025

AtaiBeckley Completes Redomiciliation to the United States

December 23, 2025

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

December 11, 2025

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio

November 13, 2025

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

November 12, 2025

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 10, 2025

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression

November 5, 2025

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies

October 20, 2025

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

October 16, 2025

atai Life Sciences Announces Pricing of Public Offering of Common Shares

Displaying 11 - 20 of 169